Accueil/Actions/SABS

SABS

USD

SAB Biotherapeutics Inc. Common Stock

$3.180+0.040 (1.274%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$3.140

Haut

$3.330

Bas

$3.140

Volume

0.08M

Fondamentaux de l'Entreprise

Capitalisation Boursière

33.1M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.27M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1Actuel $3.180Haut $6.6

Actualités Connexes

4 nov. 2025 · 13:30

GlobeNewswire

SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142

MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other

4 nov. 2025 · 13:00

GlobeNewswire

SAB BIO to Participate in Upcoming Investor Conferences

MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its